506 related articles for article (PubMed ID: 23568995)
1. [Immunotherapy targeting misfolded proteins in neurodegenerative disease].
Kanemaru K
Brain Nerve; 2013 Apr; 65(4):469-74. PubMed ID: 23568995
[TBL] [Abstract][Full Text] [Related]
2. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
Yoshida K; Higuchi K; Ikeda S
Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
[TBL] [Abstract][Full Text] [Related]
3. Targeting oligomers in neurodegenerative disorders: lessons from α-synuclein, tau, and amyloid-β peptide.
Gadad BS; Britton GB; Rao KS
J Alzheimers Dis; 2011; 24 Suppl 2():223-32. PubMed ID: 21460436
[TBL] [Abstract][Full Text] [Related]
4. Neurodegenerative diseases linked to misfolded proteins and their therapeutic approaches: A review.
Khanam H; Ali A; Asif M; Shamsuzzaman
Eur J Med Chem; 2016 Nov; 124():1121-1141. PubMed ID: 27597727
[TBL] [Abstract][Full Text] [Related]
5. Defective protein folding and aggregation as the basis of neurodegenerative diseases: the darker aspect of proteins.
Naeem A; Fazili NA
Cell Biochem Biophys; 2011 Nov; 61(2):237-50. PubMed ID: 21573992
[TBL] [Abstract][Full Text] [Related]
6. Nucleic acid aptamers for neurodegenerative diseases.
Bouvier-Müller A; Ducongé F
Biochimie; 2018 Feb; 145():73-83. PubMed ID: 29104136
[TBL] [Abstract][Full Text] [Related]
7. [Neurodegenerative conformational disease and its molecular bases].
Li WW; Cai DF; Ren HM
Sheng Li Ke Xue Jin Zhan; 2006 Apr; 37(2):97-102. PubMed ID: 16850610
[TBL] [Abstract][Full Text] [Related]
8. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
Costanzo M; Zurzolo C
Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
[TBL] [Abstract][Full Text] [Related]
9. Neurodegenerative lesions: seeding and spreading.
Duyckaerts C
Rev Neurol (Paris); 2013 Oct; 169(10):825-33. PubMed ID: 24035591
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders.
Valera E; Spencer B; Masliah E
Neurotherapeutics; 2016 Jan; 13(1):179-89. PubMed ID: 26494242
[TBL] [Abstract][Full Text] [Related]
11. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
Ciechanover A; Kwon YT
Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
[TBL] [Abstract][Full Text] [Related]
12. Walking the tightrope: proteostasis and neurodegenerative disease.
Yerbury JJ; Ooi L; Dillin A; Saunders DN; Hatters DM; Beart PM; Cashman NR; Wilson MR; Ecroyd H
J Neurochem; 2016 May; 137(4):489-505. PubMed ID: 26872075
[TBL] [Abstract][Full Text] [Related]
13. Chaperone-like antibodies targeting misfolded tau protein: new vistas in the immunotherapy of neurodegenerative foldopathies.
Zilka N; Kontsekova E; Novak M
J Alzheimers Dis; 2008 Oct; 15(2):169-79. PubMed ID: 18953106
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic applications of antibodies in non-infectious neurodegenerative diseases.
Krishnamurthy PK; Sigurdsson EM
N Biotechnol; 2011 Sep; 28(5):511-7. PubMed ID: 21473943
[TBL] [Abstract][Full Text] [Related]
15. Emerging Targets and Latest Proteomics Based Therapeutic Approaches in Neurodegenerative Diseases.
Fatima MT; Islam Z; Ahmad E; Salahuddin P
Curr Protein Pept Sci; 2018; 19(9):858-875. PubMed ID: 28762306
[TBL] [Abstract][Full Text] [Related]
16. [Are neurodegenerative diseases "protein cancers"?].
Hasegawa M
Brain Nerve; 2012 Jun; 64(6):675-9. PubMed ID: 22647475
[TBL] [Abstract][Full Text] [Related]
17. Polyphenolic compounds for treating neurodegenerative disorders involving protein misfolding.
Ho L; Pasinetti GM
Expert Rev Proteomics; 2010 Aug; 7(4):579-89. PubMed ID: 20653511
[TBL] [Abstract][Full Text] [Related]
18. The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases.
Victoria GS; Zurzolo C
J Cell Biol; 2017 Sep; 216(9):2633-2644. PubMed ID: 28724527
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy for Alzheimer's disease.
Wang W; Fan L; Xu D; Wen Z; Yu R; Ma Q
Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):807-14. PubMed ID: 22899646
[TBL] [Abstract][Full Text] [Related]
20. Heat shock proteins as suppressors of accumulation of toxic prefibrillar intermediates and misfolded proteins in neurodegenerative diseases.
Arawaka S; Machiya Y; Kato T
Curr Pharm Biotechnol; 2010 Feb; 11(2):158-66. PubMed ID: 20170473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
